231 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

—

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Daclizumab (Zinbryta®) for the treatment of relapsing (recidive) forms of multiple sclerosis (RMS)

Zorginstituut Nederland carried out a marginal assessment of the medicine daclizumab (Zinbryta ® ), whereby they came to the ...

Report | 15-12-2016

Palbociclib (Ibrance®) for the treatment of metastatic breast cancer

Zorginstituut Nederland carried out an assessment of the medicine palbociclib (Ibrance®), whereby they came to the following ...

Report | 15-12-2016

Netupitant - palonosetron (Akynzo®) for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy

Zorginstituut Nederland has assessed the medicine netupitant/palonosetron (Akynzeo®), whereby they came to the following ...

Report | 31-10-2016

Zinnige Zorg room for improvement report - Appropriate use of pharmaceutical products for patients with castration-refractory prostate cancer

Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

Report | 29-07-2016

Zinnige Zorg room for improvement report - Appropriate post-treatment surveillance of women treated for breast cancer

Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

Report | 25-07-2016

Fingolimod (Gilenya®)

Zorginstituut Nederland has advised on amending the conditional inclusion of the medicine fingolimod (Gilenya®) in the Medicines ...

Report | 08-07-2016

Future scenarios about drug development and drug pricing

This report is the result of a consultative and deliberative process — initiated by the Belgian Healthcare Knowledge Centre (KCE) ...

Report | 28-06-2016

Guideline for economic evaluations in healthcare

This new Guideline unifies all previously available Dutch guidelines, links up with international developments, provides un ...

Guideline | 16-06-2016

Tranylcypromine (Tracydal®) in patients with a severe multi-resistant depressive disorder

Zorginstituut Nederland carried out a budget impact analysis for the medicine tranylcypromine (Tracydal®). They reached the ...

Report | 15-06-2016

Tolperison (Tolpermyo®)

Zorginstituut Nederland has drawn up a pharmacotherapeutic report for the medicine tolperison (Tolpermyo®), whereby it reached ...

Report | 25-05-2016

Go to